| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |